Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Munich - Delayed Quote EUR

Bristol-Myers Squibb Co (BRM.MU)

42.12
-2.24
(-5.06%)
As of 8:13:18 AM GMT+2. Market Open.
Advanced Chart
Loading Chart for BRM.MU
  • Previous Close 44.36
  • Open 42.12
  • Bid 42.08 x --
  • Ask 42.21 x --
  • Day's Range 42.12 - 42.12
  • 52 Week Range 36.78 - 58.12
  • Volume 0
  • Avg. Volume 38
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Jul 31, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: BRM.MU

View More
View More

Performance Overview: BRM.MU

Trailing total returns as of 5/7/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BRM.MU
21.68%
S&P 500 (^GSPC)
4.25%

1-Year Return

BRM.MU
8.62%
S&P 500 (^GSPC)
8.56%

3-Year Return

BRM.MU
33.44%
S&P 500 (^GSPC)
36.59%

5-Year Return

BRM.MU
9.41%
S&P 500 (^GSPC)
95.47%

Compare To: BRM.MU

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

BRM.MU
Bristol-Myers Squibb Co
42.12
-5.06%
Mkt Cap EUR -
Industry Drug Manufacturers—General
AZN.L
AstraZeneca PLC
10,504.00
-1.83%
Mkt Cap GBp 162.833B
Industry Drug Manufacturers—General
GSK.L
GSK plc
1,379.00
-4.90%
Mkt Cap GBp 56.062B
Industry Drug Manufacturers—General
PFE
Pfizer Inc.
22.92
+0.17%
Mkt Cap 130.309B
Industry Drug Manufacturers—General

Statistics: BRM.MU

View More

Valuation Measures

As of 5/6/2025

  • Market Cap

    85.58B

  • Enterprise Value

    120.46B

  • Trailing P/E

    18.72

  • Forward P/E

    7.36

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.14

  • Price/Book (mrq)

    5.87

  • Enterprise Value/Revenue

    2.86

  • Enterprise Value/EBITDA

    8.41

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

View More

Research Analysis: BRM.MU

View More
View More

People Also Watch

BRM.F Bristol-Myers Squibb Company
41.97
-0.08%
 
BRM.DU Bristol-Myers Squibb Co
41.85
-0.78%
 
BRM.DE Bristol-Myers Squibb Company
42.11
-1.84%
 
BRM.BE Bristol-Myers Squibb Co
41.86
-4.93%
 
BRM.HM Bristol-Myers Squibb Co
42.00
-1.94%
 
BRM.SG Bristol-Myers Squibb Co
42.03
+0.33%
 
SNW2.F Sanofi
45.60
-4.20%
 
4AB.F AbbVie Inc.
165.20
-3.73%
 
JNJ.SG Johnson & Johnson
138.60
+2.23%
 
BMY.MX Bristol-Myers Squibb Company
943.40
+0.02%
 
BMY.BA Bristol-Myers Squibb Company
18,450.00
-3.91%